Tag Archives: percutaneous transluminal angioplasty

Four-year results from EU RCT validate the long-term safety profile of Philips’ Stellarex low-dose Drug-Coated Balloon

Posted on 26, June 2020 by EuropaWire PR Editors

(PRESS RELEASE) AMSTERDAM, 26-Jun-2020 — /EuropaWire/ — The global leader in health technology Royal Philips (NYSE: PHG, AEX: PHIA) has announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). New data from the EU RCT reconfirms … Read the full press release →

Posted in Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology

Tagged Chris Landon, EU RCT, health technology, ILLUMENATE European Randomized Controlled Trial, ILLUMENATE Pivotal trial, Marianne Brodmann MD, percutaneous transluminal angioplasty, peripheral arterial disease, Philips EnduraCoat technology, Philips’ Stellarex low-dose Drug-Coated Balloon, polyethylene glycol, PTA, RCT, Royal Philips, Stellarex DCB, Vascular Interventional Advances, VIVA, William Gray MD